Knipper is a company based in the United States, operating within the Business Services industry, with a focus on sectors such as pharmaceuticals and biotechnology. Founded in 1986, it employs between 1,001 and 5,000 individuals and reported revenues of approximately $396 million. The company specializes in providing solutions related to serialization and compliance with the FDA’s Drug Supply Chain Security Act (DSCSA). A recent document emphasizes the complexities and challenges associated with implementing DSCSA requirements, which mandate that pharmaceutical manufacturers serialize individual units and ensure electronic tracking throughout the supply chain. The document discusses the importance of proper labeling and encoding, adherence to GS1 standards, and the necessity for thorough planning to avoid compliance issues. Additionally, it highlights the significance of understanding the various exceptions to the DSCSA law and maintaining comprehensive documentation to facilitate consistent execution. Overall, Knipper's expertise appears to center on navigating regulatory requirements in the pharmaceutical sector, particularly in relation to serialization and supply chain management.